New Key Statistics Module, Z-Score and F-Score
SZSE:301096 Key Ratios
Market Cap ¥ M | 4,364.76 |
Enterprise Value ¥ M | 4,551.25 |
P/E(ttm) | 20.39 |
PE Ratio without NRI | 17.86 |
Forward PE Ratio | 12.88 |
Price/Book | 1.58 |
Price/Sales | 4.19 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | 0.13 |
Revenue (TTM) ¥ M | 1,025.00 |
EPS (TTM) ¥ | 1.96 |
Beneish M-Score | -1.27 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 53.60 |
y-y EBITDA Growth Rate % | -21.00 |
EV-to-EBIT | 21.66 |
EV-to-EBITDA | 21.66 |
PEG | 0.33 |
Shares Outstanding M | 109.23 |
Net Margin (%) | 20.69 |
Operating Margin % | 23.19 |
Pre-tax Margin (%) | 19.71 |
Quick Ratio | 1.75 |
Current Ratio | 1.94 |
ROA % (ttm) | 5.71 |
ROE % (ttm) | 7.80 |
ROIC % (ttm) | 9.09 |
Dividend Yield % | 0.74 |
Altman Z-Score | 3.63 |
SZSE:301096 Number of Guru Trades
SZSE:301096 Volume of Guru Trades
Gurus Latest Trades with SZSE:301096
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:301096 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Hangzhou Bio-Sincerity Pharma-Tech Co Ltd Insider Transactions
No Available Data